Guardian Pharmacy SErvices Inc
GRDNLatest QuantConomy context for GRDN: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Guardian Pharmacy SErvices Inc
QuantConomy has a structured record for GRDN. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- GRDN
- Name
- Guardian Pharmacy SErvices Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq
Recent signals for GRDN
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Jan 13, 12:00 AM | GRDN filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-13. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | Mar 11, 12:00 AM | GRDN filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-03-11. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| executive change | neutral | 85 | Jun 22, 08:40 PM | GRDN filed 8-K: Director or Officer Changes, Regulation FD Disclosure - 2 material events - [very strong neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| GRDN | NYSE | alphavantage | Guardian Pharmacy Services Inc |
| GRDN | NYSE | alpaca | Guardian Pharmacy Services, Inc. |
| GRDN | NYSE | fmp | Guardian Pharmacy Services, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | LEWIS RANDALL J | Director | grant | 4,028 | $0.00 | $0 | 4 on EDGAR |
| May 5, 2026 | Patchett Mary Sue | Director | grant | 4,028 | $0.00 | $0 | 4 on EDGAR |
| May 5, 2026 | COSLER STEVEN D | Director | grant | 4,028 | $0.00 | $0 | 4 on EDGAR |
| — | Weir Robert | See Remarks | — | — | — | — | 3 on EDGAR |
| — | Crisafulli Chris | See Remarks | — | — | — | — | 3 on EDGAR |
| — | Martin David Norman | See Remarks | — | — | — | — | 3 on EDGAR |
| — | Tuch Jeffrey | See Remarks | — | — | — | — | 3 on EDGAR |
| — | Eakins Richard | Senior Vice President, Sales | — | — | — | — | 3 on EDGAR |
| — | Mudd William Franklin | Senior Vice President, Finance | — | — | — | — | 3 on EDGAR |
| — | Towns Douglas | See Remarks | — | — | — | — | 3 on EDGAR |
| Mar 28, 2026 | Ackerman John | Director | exercise | 1,413,939 | — | — | 4 on EDGAR |
| Mar 28, 2026 | Bindley Capital Partners I, LLC | 10% owner | exercise | 6,100,175 | — | — | 4 on EDGAR |
| Mar 28, 2026 | BINDLEY WILLIAM E | Director, 10% owner | exercise | 6,100,175 | — | — | 4 on EDGAR |
| Mar 28, 2026 | Cardinal Equity Fund, L.P. | Insider | exercise | 471,057 | — | — | 4 on EDGAR |
| Mar 28, 2026 | Forbes Kendall | See Remarks | exercise | 608,570 | — | — | 4 on EDGAR |
| Mar 28, 2026 | Pharmacy Investors, LLC | Insider | exercise | 1,413,939 | — | — | 4 on EDGAR |
| Mar 28, 2026 | Morris David K | See Remarks | exercise | 641,869 | — | — | 4 on EDGAR |
| Mar 28, 2026 | Salentine Thomas J Jr | Director, 10% owner | exercise | 6,100,175 | — | — | 4 on EDGAR |
| Mar 28, 2026 | Burke Fred | See Remarks | exercise | 1,298,826 | — | — | 4 on EDGAR |
| Mar 20, 2026 | Cardinal Equity Fund, L.P. | Insider | sale | 275,728 | $29.68 | $8,184,296 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query GRDN context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access